BSP Pharmaceuticals S.p.A. is proud to announce Its participation to the 4th Annual World ADC Asia Summit of Incheon 2025.
The 4th World ADC Asia Summit returns to Incheon as the most comprehensive antibody-drug conjugate conference serving the Asian community.
It's the asian session of World ADC Summit, to showcasing novel ADC technologies, improving Clinical trial Design and reducing cost and optimizing efficiency of manufacturing to establish Clinical validation of the next wave of ADCs.
Asia is becoming one of the most exciting region within the ADC world, with a rapid rise in new companies, billions of dollars’ worth of investment and partnerships involving Asian companies, and an everexpanding breadth of new technologies being explored.
BSP's team looks forward to meeting You at our booth #30 in the Exhibitor area Save the Date!!! Next Wednesday, 11th of June, our Giorgio Salciarini – Head of Sales, Technical Business Development – will present its speech: “: A Step Ahead Against the Challenges of the Bioconjugates” during the Scientific Program Day1, starting from 16:00 PM.
To request a meeting and for any other info, You can send an e-mail at Business.Development@Bsppharmaceuticals.com
